[PDF][PDF] Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
Summary Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
[HTML][HTML] Characterizations of enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu… - 2022 - europepmc.org
Abstract Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a local
growth advantage over BA. 2.38, BA. 2.76 and BA. 5 in India. The underlying mechanism of …
growth advantage over BA. 2.38, BA. 2.76 and BA. 5 in India. The underlying mechanism of …
[HTML][HTML] Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu… - Cell Host & Microbe, 2022 - Elsevier
Summary Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
[HTML][HTML] Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian… - Cell Host & …, 2022 - ncbi.nlm.nih.gov
Abstract Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
Characterizations of enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu… - bioRxiv, 2022 - biorxiv.org
Abstract The Omicron subvariants BA. 2.75 is rapidly raising in India. BA. 2.75 also shows a
local growth advantage compared to BA. 2.38 and BA. 4/BA. 5. Its immune evasion …
local growth advantage compared to BA. 2.38 and BA. 4/BA. 5. Its immune evasion …
Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75.
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu… - 2022 - repository.cam.ac.uk
Abstract Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue… - Cell host & …, 2022 - pubmed.ncbi.nlm.nih.gov
Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75.
Y Cao, W Song, L Wang, P Liu, C Yue, F Jian… - Cell Host & …, 2022 - europepmc.org
Abstract Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75
Y Cao, W Song, L Wang, P Liu, C Yue… - Cell host & …, 2022 - pubmed.ncbi.nlm.nih.gov
Recently emerged SARS-CoV-2 Omicron subvariant, BA. 2.75, displayed a growth
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …
advantage over circulating BA. 2.38, BA. 2.76, and BA. 5 in India. However, the underlying …